Similar documents
›Áfi¡ŒÎ“F’æ’¶

スライド タイトルなし

% ORG/WIKI/FILE:SALKWS.JPG 1. ORG/WIKI

第122号.indd

234 50cm

untitled

Microsoft Word - 01マニュアル・入稿原稿p1-112.doc

et al No To Shinkei Clin Neurol Neurology et al J Neurosurg et al Arch Neurol et al Angiology

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate

PSCHG000.PS




RX501NC_LTE Mobile Router取説.indb

yamato_2016_0915_色校_CS3.indd


UX-V503CL/UX-V503CW

日経テレコン料金表(2016年4月)

B

73 p p.152


Microsoft Word - 田中亮太郎.doc

_Print

122011pp

2

A p A p. 224, p B pp p. 3.

p

Microsoft Word - 映画『東京裁判』を観て.doc

9

() L () 20 1

308 ( ) p.121

広報かみす 平成28年6月15日号

.

戦後の補欠選挙

スラヴ_00A巻頭部分


人間石川馨と品質管理


.V...z.\

201604_建築総合_2_架橋ポリ-ポリブテン_cs6.indd

学術フロンティア推進事業プロジェクト研究シリーズ 12

Microsoft PowerPoint - masayukiakiyama_ pptx

u u u 1 1



GJG160842_O.QXD

st 202nd 203rd 204th 205th 206th 207th 208th


00_Cover.pmd

07-第4章村上英吾.indd

untitled

腎不全-第22回.indd

109

42 3 u = (37) MeV/c 2 (3.4) [1] u amu m p m n [1] m H [2] m p = (4) MeV/c 2 = (13) u m n = (4) MeV/c 2 =

_??_ Fig. 1. Annual number of subjects who were bitten by possibly rabid animals in the rabies endemic regions and thereafter visited our vaccine clin

2

本組よこ/根間:文11-11_P131-158

Taro10-名張1審無罪判決.PDF

Message from SENDENKAIGI

…h…L…–…†…fi…g1

2006

SBP hospitalist network.key

,,, (Hz), AM (1MHz), 300m, 24 (245GHz), 12cm, 212 (electromagnetic fields), (electromagnetic radiations) (NIR),X,,,, RF, ELF,,, ,, 2005

日本皮膚科学会雑誌第121巻第14号

neutrino


Global Commission for the Certification of the Eradication of Poliomyelitis GCC 1 Global action plan for laboratory containment of wild polio

h4_1_et

11月/庵原俊昭





がん患者の終末期ケアにおける通所リハビリテーションの役割 介護保険によるがん終末期ケアの可能性

Power Transformation and Its Modifications Toshimitsu HAMASAKI, Tatsuya ISOMURA, Megu OHTAKI and Masashi GOTO Key words : identity transformation, pow


_02三浦.indd

The Heart Healthy Tocotrienol Complex Tocomin SupraBio

Synagis RS RSRespiratory Syncytial Virus RSBPD CHDRS RS RS BPD CHD 50mg100mg RS20138 RS Respiratory Syncytial Virus RS

13●53頁●6-7▲院内感染対策▲.ppt

Taro13-学習ノート表紙.PDF

P15 P211 1 P1 P4 P2 P3 P4 P17


Mantel-Haenszelの方法

4 2 p = p(t, g) (1) r = r(t, g) (2) p r t g p r dp dt = p dg t + p g (3) dt dr dt = r dg t + r g dt 3 p t p g dt p t r t = Benefit view dp

™·”õ/sec3_p63_84/fiü“eflÅ


FAO Animal Health Manual No

idwr2008_21

48 皮 膚 第29巻 第1号 昭 和62年2月 第1-b図 第1-a図 第1図Micro Trak法 アッ 皮 細 胞 中あ るいは細 pin point sizeの による 胞 外に,アッ 粒子と 直 接 塗 抹 標本から プル グ リ ー ン に光 プル し てelelnentary る 粒子

エンゲルス『イギリスにおける労働階級の状態』

Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood

Structure and Strength of Acid-Base in Aqueous Medium Aritsune KAJI* and Masaru NAKAHARA* * Department of Chemistry, Faculty of Science, Kyoto Univers

pg. 2

産衛誌57-4たより.indb

442号

経済論集 46‐2(よこ)(P)☆/2.三崎

w 2 22



Transcription:

3 1570-1085 1085 BC 5 1157 BC

569 (A.D.) Marium Varius Variola 910 (A.D.) Al-Razi Razi * Pediatr Inf Dis J 1999; 18:85-93

400 (A.D.)

568 Elephant 1507 1520 1524 1555 1713 1738 1776

18

Marcus Aurelius 180 2 1650 1654 2 1730 15 1774 Pediatr Inf Dis J 1999; 18:85-93

Variolation (Variolation)

10 * 15 20 40 50 8 Uvularia grandiflora 2 6 1 * Fenner et al. Smallpox and its Eradication. p252

1798, (Cowpox) Cowpox) Variolae Vaccinae Variolae Vaccinae * Pediatr Inf Dis J 1999; 18:85-93

1796

Sarah Nelmes Sarah Nelmes 16 1796

982 Variolation 10 1650 1667 Inoculation Haygarth 1793

Variolation Variolation 1721 1721-1792 1792 97 97 2.0 2.0 9152 9152 30 30 132 132 1792 1792 95 95 0.9 0.9 4121 4121 33 33 122 122 1778 1778 90 90 0.6 0.6 4988 4988 10 10 304 304 1776 1776 87 87 0.9 0.9 4977 4977 18 18 699 699 1764 1764 28 28 1.4 1.4 2124 2124 10 10 5545 5545 1752 1752 10 10 3.0 3.0 400 400 14 14 3600 3600 1730 1730 5 2.1 2.1 287 287 15 15 5759 5759 1721 1721 Variolation Variolation % CFR CFR Variolation Variolation CFR CFR

1805 1864 Vaccination 1940 Collier * Henderson DA, Moss M, Smallpox and Vaccinia in Vaccines, 3 rd edition, 1999

1945

98%

* Dowdle WR, Hopkins DR, The Eradication of Infectious Diseases, John Wiley & Sons, Chichester 1998. pp47-59

1950 1959 1966 Pan American Sanitary Organization Henderson DA, Moss B, Smallpox and Vaccinia in Vaccines, 3 rd edition, 1999

1967 Henderson DA, Moss B, Smallpox and Vaccinia in Vaccines, 3 rd edition, 1999

1967 Endemic

Henderson DA, Moss B, Smallpox and Vaccinia in Vaccines, 3 rd edition, 1999

(Mass Vaccination)

*4 Modified from Epid Rev 1993;15: 265-302, Am J Prev Med 2001; 20 (4S): 88-153, MMWR 2000; 49 (SS-9); 27-38 R o 6-7 12-18 18 4-7 12-17 17 5-7 6-7 5-7 1999 19-35 35 85%* 83-94% 75-86% 92-94% 94% 80-86% 86% 83-85% 85% 80-85% 85% 83%* 92% 92% 83%* 90% 92% 1997-1998 1998 9% 96% 97% 97% 97% 97%

6 7 N-95

36-47 5 73-88 3 58% in Fenner F et al. Smallpox and its Eradication, pp200

Bull WHO 1975; 52: 209-222 26.2 26.2 12 12 45 45 Gerere Gerere 40.0 40.0 4 10 10 N Game Game 44.4 44.4 12 12 27 27 100 100

75 3 4 5 6 7 60 28 8 96 62.5 29.2 8.3 100.0 Am J Epidemiology 1974; 99: 291-302

26/27 10 5/115 10 8/65 96% 4% 12% From Mack et al, Summarized in Fenner et al. Smallpox and its eradication, pg 688

- 0 4 5-14 15-29 30-49 >50 50 0% 45% 0% 10.5% 0.7% 13.9% 3.7% 54.2% 5.5% 50.0% From Outbreak in Liverpool, England, 1902-1903 In Fenner F et al. Smallpox and its Eradication, pp53

1950-1971 1971 0 10 11 20 >20 52% 29% 1.4% 7% 11% In Fenner F et al. Smallpox and its Eradication, pp53

29.5% 47.6% 10 75.0 96.3 7 1.9 21.8 in Fenner F et al. Smallpox and its Eradication, pp 591

3, 1,000 1,000 2.4 1st and 2nd visit, 1-2 days apart Am J Epidemiolgy 1974; 99: 303-313 24.2 24.4 8.5 13.2 92.6 28.2 32.5

7 7 1968-1970 1970 Heiner et al Amer J Epidemiol 1971; 91:316-326 (N) 258 206 302 160 449 15 (N) 45 45 81 10 91 0 AR (%) 17.4 22.3 26.8 6.3 20.3 0

400,000

1972 5 1 1973 64 1 1974 416

Kuralia, Bhola

** Rahima Banu 1975 10 16 Ali Maow Maalin 1977 10 26 - - ** 1978 2

1980

Ken Alibek 1980 JAMA 1999; 281: 2127-2137